Abstract
e21643Background: Despite its effectiveness proven in a wide range of oncologic malignancies, use of high dose methotrexate (MTX) regimen is limited by potentially lethal non-hematologic toxicities...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
